CN1546143A - Luyang kidney yang strengthening Chinese traditional medicinal formula and its preparation - Google Patents
Luyang kidney yang strengthening Chinese traditional medicinal formula and its preparation Download PDFInfo
- Publication number
- CN1546143A CN1546143A CNA2003101182259A CN200310118225A CN1546143A CN 1546143 A CN1546143 A CN 1546143A CN A2003101182259 A CNA2003101182259 A CN A2003101182259A CN 200310118225 A CN200310118225 A CN 200310118225A CN 1546143 A CN1546143 A CN 1546143A
- Authority
- CN
- China
- Prior art keywords
- kidney
- preparation
- make
- fructus
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000003734 kidney Anatomy 0.000 title claims abstract description 74
- 238000002360 preparation method Methods 0.000 title claims abstract description 53
- 238000005728 strengthening Methods 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract description 81
- 230000008569 process Effects 0.000 claims abstract description 15
- 241000282994 Cervidae Species 0.000 claims description 46
- 239000003814 drug Substances 0.000 claims description 46
- 239000000843 powder Substances 0.000 claims description 37
- 210000001550 testis Anatomy 0.000 claims description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 239000002775 capsule Substances 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 238000001035 drying Methods 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 18
- 239000008187 granular material Substances 0.000 claims description 15
- 239000002674 ointment Substances 0.000 claims description 15
- 241000726128 Aeshna Species 0.000 claims description 13
- 241000282465 Canis Species 0.000 claims description 13
- 239000003610 charcoal Substances 0.000 claims description 13
- 210000001320 hippocampus Anatomy 0.000 claims description 13
- 210000003899 penis Anatomy 0.000 claims description 13
- 239000012153 distilled water Substances 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 12
- 239000002671 adjuvant Substances 0.000 claims description 9
- 239000006187 pill Substances 0.000 claims description 9
- 235000020357 syrup Nutrition 0.000 claims description 9
- 239000006188 syrup Substances 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 7
- 229920001353 Dextrin Polymers 0.000 claims description 6
- 239000004375 Dextrin Substances 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 6
- 235000019425 dextrin Nutrition 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- 235000020374 simple syrup Nutrition 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- 238000005516 engineering process Methods 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 230000002421 anti-septic effect Effects 0.000 claims description 3
- -1 drying Substances 0.000 claims description 3
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- MUKYLHIZBOASDM-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid 2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound NC(=N)N(C)CC(O)=O.OCC(O)C(O)C(O)C(O)C(O)=O MUKYLHIZBOASDM-UHFFFAOYSA-N 0.000 abstract 1
- 241000255789 Bombyx mori Species 0.000 abstract 1
- 241000212948 Cnidium Species 0.000 abstract 1
- 241001478425 Hippocampus japonicus Species 0.000 abstract 1
- 241001446509 Psoralea Species 0.000 abstract 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 abstract 1
- 244000223014 Syzygium aromaticum Species 0.000 abstract 1
- 241001533104 Tribulus terrestris Species 0.000 abstract 1
- 229910052891 actinolite Inorganic materials 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 17
- 241001465754 Metazoa Species 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 241000700159 Rattus Species 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 10
- 201000010653 vesiculitis Diseases 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 7
- 230000037396 body weight Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 244000309464 bull Species 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- 238000001802 infusion Methods 0.000 description 5
- 229960003604 testosterone Drugs 0.000 description 5
- 208000031975 Yang Deficiency Diseases 0.000 description 4
- 230000003285 pharmacodynamic effect Effects 0.000 description 4
- 210000002381 plasma Anatomy 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 206010063659 Aversion Diseases 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000012449 Kunming mouse Methods 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000003779 hair growth Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 210000000918 epididymis Anatomy 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 230000002381 testicular Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese preparation for treating kidney deseases and process for preparation, which comprises the followingraw materials (by weight ratio), puncturevine 5-25%, silkworm moth 5-20%, Hippocampus japonicus 5-20%, dog kidney 5-20%, actinolite 3-15%, cnidium fruit 5-20%, cloves 3-15%, psoralea fruit 2-10%.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation and preparation method for the treatment of the kidney yang deficiency syndrome, this Chinese medicine preparation can be treated kidney yang deficiency syndromes such as soreness of waist and knee joint, aversion to cold and cold limbs, the vertigo, lassitude, hyposexuality.
Background technology
The multiple disease symptoms that kidney yang deficiency shows, due to being impairment of the kidney by innate deficiency of YANG in the body, year high deficiency of the kidney, overfatigue, prolonged illness, this disease makes function of human body old and feeble in advance, sexual hypofunction, lassitude; clear urine in large amounts or frequent has influenced quality of life of people greatly, brings spirit and sensual misery for the disease patient; the medicine for the treatment of this disease in the market has NANBAO, Menstruation-Regulating Capsule etc. and many health product; but its drug effect is not obvious, and cure rate is low, does not have better therapeutic effect.
Summary of the invention
In order to overcome the deficiencies in the prior art, the invention provides a kind of kidney invigorating and YANG supporting deer postcoital protrusion kidney Chinese medicine preparation and preparation method, this Chinese medicine preparation can effectively be regulated function of human body, the kidney invigorating essence, strong life fire, the hair growth promoting effect of fire, emerging positive heroic undertaking is mutually arranged, the symptomes complice that can Comprehensive Treatment causes by kidney yang deficiency, as diseases such as soreness of waist and knee joint, aversion to cold and cold limbs, the vertigo, lassitudes, its cure rate height, curative effect is obvious.
The invention provides following technical scheme: this Chinese medicine preparation is formulated by following raw materials according percentage ratio by weight: Fructus Tribuli 5-25%, Os Canitis charcoal 5-20%, Bombycis mori 5-20%, red Aeschna melanictera 5-20%, Penis et testis cervi 3-15%, Hippocampus 5-20%, Testis et Pentis Canis 5-20%, Actinolitum 3-15%, Fructus Cnidii 5-20%, Fructus Caryophylli 3-15%, Fructus Psoraleae 2-10%
It is formulated that described raw material is suitable for proportioning by the best by following weight: it is formulated that described raw material is suitable for proportioning by the best by following weight: Fructus Tribuli 12.0%, Os Canitis charcoal 10.9%, Bombycis mori 10.9%, red Aeschna melanictera 10.9%, Penis et testis cervi 7.8%, Hippocampus 9.6%, Testis et Pentis Canis 10.3%, Actinolitum 7.2%, Fructus Cnidii 9.6%, Fructus Caryophylli 6.0%, Fructus Psoraleae 4.8%.
Described Chinese medicine preparation can be made into tablet, capsule, granule, powder, pill, oral liquid, syrup and other clinical acceptable forms.
The preparation method of described tablet, make by following process: (1) is got Fructus Tribuli, Actinolitum, Fructus Cnidii and is ground into thick piece, add above 3-10 times of water gaging of each component gross weight, heating decocts 1-3 time, each 1-4 hour, gradation filtered, merging filtrate, be concentrated into paste, the relative density in the time of its 60 ℃ is 1.0-1.5; (2) get Os Canitis charcoal, red Aeschna melanictera, Penis et testis cervi, Hippocampus, Testis et Pentis Canis and be ground into 60-120 order fine powder; (3) getting above each the component gross weight 3-8 of Bombycis mori, Fructus Caryophylli, Fructus Psoraleae, adding, doubly to measure concentration be 40-80% ethanol, heating and refluxing extraction 2-4 time, 1-3 hour at every turn, gradation filters, merging filtrate reclaims ethanol and is concentrated into paste, and 60 ℃ relative density is 1.0-1.5; (4) ointment that (1) method, (3) method are made mixes with the medicated powder that (2) method makes, and 60-100 ℃ of drying pulverized, and sieves, and starch or dextrin and other adjuvants are made granule, drying, and granulate adds magnesium stearate or other adjuvants, and compacting is in flakes.
The preparation method of described capsule, make by following process: get the ointment that (1) method in the above-mentioned method for preparing tablet thereof, (3) method make and mix with the medicated powder that (2) method makes, 60-100 ℃ of drying pulverized, and sieves, and incapsulates.
The preparation method of described granule, make by following process: get the ointment that (1) method in the above-mentioned method for preparing tablet thereof, (3) method make and mix with the medicated powder that (2) method makes, 60-100 ℃ of drying pulverized, sieve, starch or dextrin and other adjuvants are made granule.
The preparation method of described powder, make by following process: get the ointment that (1) method in the above-mentioned method for preparing tablet thereof, (3) method make and mix with the medicated powder that (2) method makes, 60-100 ℃ of drying pulverized promptly.
The preparation method of described pill, make by following process: get the ointment that (1) method in the above-mentioned method for preparing tablet thereof, (3) method make and mix with the medicated powder that (2) method makes, 60-100 ℃ of drying is ground into powder; The Mel of the grain weight of getting it filled amount 80-130% boils, and filters; Behind medicated powder, 80-130% Mel and 0-15% water mix homogeneously, make pill.
The preparation method of described oral liquid, make by following process: (1) is got Fructus Tribuli, Actinolitum, Fructus Cnidii, Os Canitis charcoal, red Aeschna melanictera, Penis et testis cervi, Hippocampus, Testis et Pentis Canis and is ground into thick piece, add above 3-10 times of water gaging of each component gross weight, heating decocts 1-3 time, each 1-4 hour, gradation filtered, merging filtrate, be concentrated into paste, 60 ℃ of relative densities are 1.0-1.5; (2) getting above each the component gross weight 3-8 of Bombycis mori, Fructus Caryophylli, Fructus Psoraleae, adding, doubly to measure concentration be 40-80% ethanol, heating and refluxing extraction 2-4 time, 1-3 hour at every turn, gradation filters, merging filtrate reclaims ethanol and is concentrated into paste, and 60 ℃ of relative densities are 1.0-1.5; (3) concentrated medicament that (1) method, (2) method is made merges, and filters, and adds the antiseptic of medicinal liquid gross weight 0.1-1%, the correctives mix homogeneously of 0.1-2%, makes oral liquid.
The preparation method of described syrup, make by following process: (1) will merge by the concentrated medicament that above-mentioned oral liquid preparation technology (1), (2) make, and filters; (2) sucrose is dissolved in the distilled water that boils, academic title's concentration is the simple syrup of 85% (g/ml) or 64.7% (g/g); (3) will filter the back medicinal liquid and add in the simple syrup, and add an amount of distilled water and make syrup.
This Chinese medicine preparation has carried out a large amount of clinical trials of a large amount of animal acute toxicity tests, long-term toxicity test for animals, animal pharmacodynamics test and treatment disease, and the use link of this medicine input being treated disease provides science and objective foundation.Its test method and result of the test are as follows respectively:
1, deer postcoital protrusion kidney capsules animal acute toxicity test:
Medicine: deer postcoital protrusion kidney capsules 0.4g powder/grain, be brown ceramic powder, content is 1.82g crude drug/g powder, is made into 0.33g powder/ml (Cmax) with distilled water during experiment, is provided by the LiaoYuan YaDong Medicine Co., Ltd., Jilin Province.
Experimental animal: Kunming mouse, body weight 20-22g, male and female half and half are provided by Norman Bethune Medical University animal portion experimental center, the quality certification number: 98050103.
Purpose: observe the toxic reaction situation of once taking in a large number.
Method and result: get 20 fasting of kunming mice 12 hours, can't help water, in 24 hours, gavage deer postcoital protrusion kidney capsules 3 times, each 0.4ml/10g is heavy, accumulation irritate to be fed maximum volume 2-4ml/20g and (is equivalent to 72g crude drug/kg), observed 7 after the administration, do not have dead the generation, animal activity freely, hair color gloss, diet is as usual, do not see other unusual performance, because of the administration volume, concentration all reaches to greatest extent, admittedly fail to obtain LD50, the maximum tolerated dose of its gastric infusion＞72g crude drug/kg is equivalent to 396 times of the clinical application amount (0.4g powder/grain * 5 * 3 * 1.82g crude drug/g powder ÷ 60kg=0.182g crude drug/kg).As seen this medicine does not have acute toxic reaction, is a kind of than safe drugs.
2, deer postcoital protrusion kidney capsules long-term toxicity test for animals:
Medicine: deer postcoital protrusion kidney capsules, face the time spent to be made into 40% suspension, provide by the LiaoYuan YaDong Medicine Co., Ltd., Jilin Province.
Experimental animal: rat, portion provides by the Norman Bethune Medical University animal.
Method and result: adopt 80 of adult rat, male and female half and half, body weight 80-120g is divided into four groups at random, and 20 every group, 1) the blank group: irritate stomach with tap water every day; 2) deer postcoital protrusion kidney capsules low dose group: irritate stomach with 1.8g/kg; 3) dosage group in the deer postcoital protrusion kidney capsules, 9g/kg; 4) deer postcoital protrusion kidney capsules high dose group: irritate stomach with 18g/kg.Once a day, successive administration three months is observed the rat general state during the successive administration, once surveyed body weight in 10 days, puts to death after March, gets blood and does inspections such as routine blood test, liver function, kidney merit, observes internal organs, carries out histopathologic examination.
Result of the test shows: deer postcoital protrusion kidney capsules is safe and reliable, and rat body weight, kidney merit, liver function and hematological examination are not all had obvious influence.
3, animal pharmacodynamics test
Test objective: cure mainly relevant main pharmacodynamics by animal experiment observation deer postcoital protrusion kidney capsules with function and test, for its clinical practice provides the pharmacodynamics test foundation.
Trial drug: deer postcoital protrusion kidney brown ceramic powder, the time spent is made into the solution of desired concn with distilled water, and use for oral administration is provided by the LiaoYuan YaDong Medicine Co., Ltd., Jilin Province.
Experimental animal: Male Kunming strain mice, rat, body weight is respectively 11-15g, 120 ± 20g, portion provides by the Norman Bethune Medical University animal.
Testis removes art: with the bull mice with etherization after, cut skin of scrotum, extract testis and epididymis, skin suture then.
Test method:
1) deer postcoital protrusion kidney capsules is to the influence of bull castration mouse prostate-Seminal vesicle weight
Remove 40 of gesture mices, be divided into four groups at random, press the drug dose gastric infusion shown in the table 1, once a day, successive administration ten days, matched group are given the equal-volume distilled water, treat after the last administration 1 hour, with the animal sacrificed by decapitation, extract prostate-Seminal vesicle, peel off fat, weigh, the results are shown in Table 1.
By table 1 result as seen, deer postcoital protrusion kidney can make male mice prostate-Seminal vesicle, and weight obviously increases, and three dosed administration groups are compared with matched group all utmost point significant difference P＜0.001, illustrates that this medical instrument has yang invigorating functions.
Group dosage (g/kg) Mus number (only) prostate-Seminal vesicle (mg/10g body weight) table 1
Matched group-10 4.32 ± 0.491
Deer postcoital protrusion kidney 2.73 10 10.15 ± 0.714 P＜0.001***
Deer postcoital protrusion kidney 2.27 10 7.97 ± 0.418 P＜0.001***
Hui Erchun organizes 1.82 10 6.53 ± 0.567 P＜0.05*
B) deer postcoital protrusion kidney capsules is to the influence of teenage male mice testis prostate-Seminal vesicle weight
Get 40 of teenage male mices, be divided into 4 groups at random, press the drug dose gastric infusion shown in the table 2, once a day, successive administration ten days, matched group is given the equal-volume distilled water, treats after the last administration 1 hour, and the animal dislocation is put to death, take out testis, prostate-Seminal vesicle, peel off fat, weigh, the results are shown in Table 2.
The dosage Mus is counted the heavy prostate-Seminal vesicle of testis
Group (g/kg) is (mg/10g) (mg/10g body weight) table 2 only
Matched group-10 50.29 ± 2.239 31.94 ± 1.498
Deer postcoital protrusion kidney 2.73 10 52.99 ± 2.148 34.56 ± 3.338
Deer postcoital protrusion kidney 2.27 10 51.73 ± 3.216 35.58 ± 1.804
Hui Erchun organizes 1.82 10 55.70 ± 2.499 39.28 ± 2.204*
The result shows: deer postcoital protrusion kidney capsules can make prostate-Seminal vesicle weight obviously increase, and three kinds of dosage all can make testicular weight that increase trend is arranged, but not statistically significant.
C) to the influence of testosterone content in the teenage male rat blood plasma
Get 30 of teenage male rats, be divided into three groups at random, press the drug dose gastric infusion shown in the table 3, once a day, successive administration 15 days, matched group are given the equal-volume distilled water, treat after the last administration 1 hour, with the animal sacrificed by decapitation, get blood, measure the content of testosterone in the blood plasma, the results are shown in Table 3.By table 3 as seen, deer postcoital protrusion kidney is with 0.4g/kg, and the 0.6g/kg dosed administration can make that testosterone concentration has increase trend in the animal blood slurry, but not statistically significant.
(/ 100mg) the table 3 of testosterone concentration in group dosage (g/kg) Mus number (only) blood plasma
Matched group-10 1731.8 ± 76.58
Deer postcoital protrusion kidney 2.73 10 2142.5 ± 85.68
Deer postcoital protrusion kidney 1.82 10 2810.5 ± 96.42*
D) deer postcoital protrusion kidney is to the influence of erection duration of castration bull rat
Remove 40 of gesture bull rats, be divided into 4 groups at random, press the drug dose gastric infusion shown in the table 4, once a day, successive administration ten days, matched group is given the equal-volume distilled water, with electrical stimulation method, observes the persistent period of erecing.See Table 4.
Group dosage (g/kg) Mus number (only) erection time (min) P table 4
Normal control group-10 3.2 ± 1.63
Deer postcoital protrusion kidney 2.73 10 8.9 ± 1.43＜0.001
Deer postcoital protrusion kidney 2.275 10 9.1 ± 1.02＜0.001
Deer postcoital protrusion kidney 1.82g/kg 10 10.1 ± 2.10＜0.001
Result of the test shows: three dosage groups of deer postcoital protrusion kidney capsules are compared with matched group, all can prolong erection time P＜0.001, illustrate that this medical instrument has yang invigorating functions.
More than a plurality of tests show that deer postcoital protrusion kidney has following function: deer postcoital protrusion kidney has the obvious effect of gain of bull castration mouse prostate-Seminal vesicle, and P＜0.01 has significant differences; Teenage male mice testis, prostate-Seminal vesicle weight increase had obvious facilitation; Can increase testosterone content in the teenage male rat blood plasma; Castration bull rat duration of erecing is played the prolongation effect.These result of the tests show: deer postcoital protrusion kidney truly has kidney invigorating and YANG supporting, treatment sexual impotence, strengthens the effect of sexual function.
In order to verify clinical efficacy, this deer postcoital protrusion kidney capsules respectively in the Jilin Prov. Inst. of Chinese Medicine and Chinese Medical Science, No.2 Clinical Hospital of Bethune Medical Univ. and Attached Hospital, Changchun Chinese Medicinal College, 404 examples, 120 examples, 90 examples, 97 routine clinical observations have been passed through respectively, with reference to Ministry of Public Health relevant criterion and clinical guidance principle, at the symptomes complice of insufficiency of kidney-YANG embodiment, case is divided into treatment group and matched group, the treatment group is thrown deer postcoital protrusion kidney capsules, and each 5, every day 3 times, matched group gives NANBAO JIAONANG, sees Table 5
Group recovery from illness produce effects enabledisable effective percentage (%) table 5
Treatment organizes 303 77 92 108 26 91.4
Matched group 101 19 25 39 18 82.2
According to curative effect judging standard, treatment group total effective rate can reach more than 91.4%, the matched group total effective rate is 82.2%, credit is analysed treatment group curative effect and obviously is better than matched group by statistics, P＜0.01, simultaneously to soreness of waist and knee joint, the insufficiency of kidney-YANG symptom effects of having clear improvement such as aversion to cold and cold limbs, before and after the treatment notable difference is arranged, obviously be better than the NANBAO matched group, and through caring, liver, multiple inspections such as kidney are found to have no side effect, have no adverse reaction, be the ideal medicament of treatment deficiency of kidney-YANG syndrome, truly have the kidney invigorating essence, strong life fire, hair growth promoting is fire mutually, the effect of emerging positive heroic undertaking, treatment deficiency of kidney-YANG syndrome curative effect is certainly, safe and reliable, application value is arranged.
The specific embodiment
A kind of kidney invigorating and YANG supporting deer postcoital protrusion kidney Chinese medicine preparation can be made into tablet, capsule, granule, powder, pill, oral liquid, syrup and other clinical acceptable forms.
The preparation of raw material that its Chinese medicine preparation is pressed column weight amount percentage ratio forms: Fructus Tribuli 5-25%, Os Canitis charcoal 5-20%, Bombycis mori 5-20%, red Aeschna melanictera 5-20%, Penis et testis cervi 3-15%, Hippocampus 5-20%, Testis et Pentis Canis 5-20%, Actinolitum 3-15%, Fructus Cnidii 5-20%, Fructus Caryophylli 3-15%, Fructus Psoraleae 2-10%.
Its best proportioning is: it is formulated that described raw material is suitable for proportioning by the best by following weight: Fructus Tribuli 12.0%, Os Canitis charcoal 10.9%, Bombycis mori 10.9%, red Aeschna melanictera 10.9%, Penis et testis cervi 7.8%, Hippocampus 9.6%, Testis et Pentis Canis 10.3%, Actinolitum 7.2%, Fructus Cnidii 9.6%, Fructus Caryophylli 6.0%, Fructus Psoraleae 4.8%.
Its weight can take by weighing like this: Fructus Tribuli 12.0g, Os Canitis charcoal 10.9g, Bombycis mori 10.9g, red Aeschna melanictera 10.9g, Penis et testis cervi 7.8g, Hippocampus 9.6g, Testis et Pentis Canis 10.3g, Actinolitum 7.2g, Fructus Cnidii 9.6g, Fructus Caryophylli 6.0g, Fructus Psoraleae 4.8g.
Its tablet is made like this: (1) is got Fructus Tribuli, Actinolitum, Fructus Cnidii and is ground into thick piece, adds above 3-10 times of water gaging of each component gross weight, and heating decocts 1-3 time, each 1-4 hour, gradation filtered, merging filtrate, be concentrated into paste, the relative density in the time of its 60 ℃ is 1.0-1.5; (2) get Os Canitis charcoal, red Aeschna melanictera, Penis et testis cervi, Hippocampus, Testis et Pentis Canis and be ground into 60-120 order fine powder; (3) getting above each the component gross weight 3-8 of Bombycis mori, Fructus Caryophylli, Fructus Psoraleae, adding, doubly to measure concentration be 40-80% ethanol, heating and refluxing extraction 2-4 time, 1-3 hour at every turn, gradation filters, merging filtrate reclaims ethanol and is concentrated into paste, and 60 ℃ relative density is 1.0-1.5; (4) ointment that (1) method, (3) method are made mixes with the medicated powder that (2) method makes, and 60-100 ℃ of drying pulverized, and sieves, and starch or dextrin and other adjuvants are made granule, drying, and granulate adds magnesium stearate or other adjuvants, and compacting is in flakes.
Its capsule is made like this: get the ointment that (1) method in the above-mentioned method for preparing tablet thereof, (3) method make and mix with the medicated powder that (2) method makes, 60-100 ℃ of drying pulverized, and sieves, and incapsulates.
Its granule is made like this: get the ointment that (1) method in the above-mentioned method for preparing tablet thereof, (3) method make and mix with the medicated powder that (2) method makes, 60-100 ℃ of drying pulverized, and sieves, and starch or dextrin and other adjuvants are made granule.
Its powder is made like this: get the ointment that (1) method in the above-mentioned method for preparing tablet thereof, (3) method make and mix with the medicated powder that (2) method makes, 60-100 ℃ of drying pulverized promptly.
Its pill is made like this: get the ointment that (1) method in the above-mentioned method for preparing tablet thereof, (3) method make and mix with the medicated powder that (2) method makes, 60-100 ℃ of drying is ground into powder; The Mel of the grain weight of getting it filled amount 80-130% boils, and filters; Behind medicated powder, 80-130% Mel and 0-15% water mix homogeneously, make pill.
Its oral liquid is made like this: (1) is got Fructus Tribuli, Actinolitum, Fructus Cnidii, Os Canitis charcoal, red Aeschna melanictera, Penis et testis cervi, Hippocampus, Testis et Pentis Canis and is ground into thick piece, add above 3-10 times of water gaging of each component gross weight, heating decocts 1-3 time, each 1-4 hour, gradation filters, merging filtrate is concentrated into paste, and 60 ℃ of relative densities are 1.0-1.5; (2) getting above each the component gross weight 3-8 of Bombycis mori, Fructus Caryophylli, Fructus Psoraleae, adding, doubly to measure concentration be 40-80% ethanol, heating and refluxing extraction 2-4 time, 1-3 hour at every turn, gradation filters, merging filtrate reclaims ethanol and is concentrated into paste, and 60 ℃ of relative densities are 1.0-1.5; (3) concentrated medicament that (1) method, (2) method is made merges, and filters, and adds the antiseptic of medicinal liquid gross weight 0.1-1%, the correctives mix homogeneously of 0.1-2%, makes oral liquid.
Its syrup is made like this: (1) will merge by the concentrated medicament that above-mentioned oral liquid preparation technology (1), (2) make, and filters; (2) sucrose is dissolved in the distilled water that boils, academic title's concentration is the simple syrup of 85% (g/ml) or 64.7% (g/g); (3) will filter the back medicinal liquid and add in the simple syrup, and add an amount of distilled water and make syrup.
Claims (10)
1, a kind of kidney invigorating and YANG supporting deer postcoital protrusion kidney Chinese medicine preparation, it is characterized in that: this Chinese medicine preparation is formulated by following raw materials according percentage ratio by weight: Fructus Tribuli 5-25%, Os Canitis charcoal 5-20%, Bombycis mori 5-20%, red Aeschna melanictera 5-20%, Penis et testis cervi 3-15%, Hippocampus 5-20%, Testis et Pentis Canis 5-20%, Actinolitum 3-15%, Fructus Cnidii 5-20%, Fructus Caryophylli 3-15%, Fructus Psoraleae 2-10%.
2, kidney invigorating and YANG supporting deer postcoital protrusion kidney Chinese medicine preparation according to claim 1 is characterized in that: it is formulated that described raw material is suitable for proportioning by the best by following weight: Fructus Tribuli 12.0%, Os Canitis charcoal 10.9%, Bombycis mori 10.9%, red Aeschna melanictera 10.9%, Penis et testis cervi 7.8%, Hippocampus 9.6%, Testis et Pentis Canis 10.3%, Actinolitum 7.2%, Fructus Cnidii 9.6%, Fructus Caryophylli 6.0%, Fructus Psoraleae 4.8%.
3, kidney invigorating and YANG supporting deer postcoital protrusion kidney Chinese medicine preparation according to claim 1, it is characterized in that: described deer postcoital protrusion kidney Chinese medicine preparation can be made into tablet, capsule, granule, powder, pill, oral liquid, syrup and other clinical acceptable forms.
4, the preparation method of kidney invigorating and YANG supporting deer postcoital protrusion kidney Chinese medicine preparation according to claim 3, it is characterized in that: the preparation method of described tablet, make by following process: (1) is got Fructus Tribuli, Actinolitum, Fructus Cnidii and is ground into thick piece, add above 3-10 times of water gaging of each component gross weight, heating decocts 1-3 time, each 1-4 hour, gradation filters, merging filtrate is concentrated into paste, and the relative density in the time of its 60 ℃ is 1.0-1.5; (2) get Os Canitis charcoal, red Aeschna melanictera, Penis et testis cervi, Hippocampus, Testis et Pentis Canis and be ground into 60-120 order fine powder; (3) getting above each the component gross weight 3-8 of Bombycis mori, Fructus Caryophylli, Fructus Psoraleae, adding, doubly to measure concentration be 40-80% ethanol, heating and refluxing extraction 2-4 time, 1-3 hour at every turn, gradation filters, merging filtrate reclaims ethanol and is concentrated into paste, and 60 ℃ relative density is 1.0-1.5; (4) ointment that (1) method, (3) method are made mixes with the medicated powder that (2) method makes, and 60-100 ℃ of drying pulverized, and sieves, and starch or dextrin and other adjuvants are made granule, drying, and granulate adds magnesium stearate or other adjuvants, and compacting is in flakes.
5, the preparation method of kidney invigorating and YANG supporting deer postcoital protrusion kidney Chinese medicine preparation according to claim 3, it is characterized in that: the preparation method of described capsule, make by following process: get the ointment that (1) method in the above-mentioned method for preparing tablet thereof, (3) method make and mix with the medicated powder that (2) method makes, 60-100 ℃ of drying, pulverize, sieve, incapsulate.
6, the preparation method of kidney invigorating and YANG supporting deer postcoital protrusion kidney Chinese medicine preparation according to claim 3, it is characterized in that: the preparation method of described granule, make by following process: get the ointment that (1) method in the above-mentioned method for preparing tablet thereof, (3) method make and mix with the medicated powder that (2) method makes, 60-100 ℃ of drying, pulverize, sieve, starch or dextrin and other adjuvants are made granule.
7, the preparation method of kidney invigorating and YANG supporting deer postcoital protrusion kidney Chinese medicine preparation according to claim 3, it is characterized in that: the preparation method of described powder, make by following process: get the ointment that (1) method in the above-mentioned method for preparing tablet thereof, (3) method make and mix with the medicated powder that (2) method makes, 60-100 ℃ of drying pulverized promptly.
8, the preparation method of kidney invigorating and YANG supporting deer postcoital protrusion kidney Chinese medicine preparation according to claim 3, it is characterized in that: the preparation method of described pill, make by following process: get the ointment that (1) method in the above-mentioned method for preparing tablet thereof, (3) method make and mix with the medicated powder that (2) method makes, 60-100 ℃ of drying is ground into powder; The Mel of the grain weight of getting it filled amount 80-130% boils, and filters; Behind medicated powder, 80-130% Mel and 0-15% water mix homogeneously, make pill.
9, the preparation method of kidney invigorating and YANG supporting deer postcoital protrusion kidney Chinese medicine preparation according to claim 3, it is characterized in that: the preparation method of described oral liquid, make by following process: (1) is got Fructus Tribuli, Actinolitum, Fructus Cnidii, Os Canitis charcoal, red Aeschna melanictera, Penis et testis cervi, Hippocampus, Testis et Pentis Canis and is ground into thick piece, add above 3-10 times of water gaging of each component gross weight, heating decocts 1-3 time, each 1-4 hour, gradation filters, merging filtrate is concentrated into paste, and 60 ℃ of relative densities are 1.0-1.5; (2) getting above each the component gross weight 3-8 of Bombycis mori, Fructus Caryophylli, Fructus Psoraleae, adding, doubly to measure concentration be 40-80% ethanol, heating and refluxing extraction 2-4 time, 1-3 hour at every turn, gradation filters, merging filtrate reclaims ethanol and is concentrated into paste, and 60 ℃ of relative densities are 1.0-1.5; (3) concentrated medicament that (1) method, (2) method is made merges, and filters, and adds the antiseptic of medicinal liquid gross weight 0.1-1%, the correctives mix homogeneously of 0.1-2%, makes oral liquid.
10, the preparation method of kidney invigorating and YANG supporting deer postcoital protrusion kidney Chinese medicine preparation according to claim 3, it is characterized in that: the preparation method of described syrup, make by following process: (1) will merge by the concentrated medicament that above-mentioned oral liquid preparation technology (1), (2) make, and filters; (2) sucrose is dissolved in the distilled water that boils, academic title's concentration is the simple syrup of 85% (g/ml) or 64.7% (g/g); (3) will filter the back medicinal liquid and add in the simple syrup, and add an amount of distilled water and make syrup.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2003101182259A CN1250247C (en) | 2003-12-05 | 2003-12-05 | Luyang kidney yang strengthening Chinese traditional medicinal formula and its preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2003101182259A CN1250247C (en) | 2003-12-05 | 2003-12-05 | Luyang kidney yang strengthening Chinese traditional medicinal formula and its preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1546143A true CN1546143A (en) | 2004-11-17 |
| CN1250247C CN1250247C (en) | 2006-04-12 |
Family
ID=34337990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2003101182259A Expired - Fee Related CN1250247C (en) | 2003-12-05 | 2003-12-05 | Luyang kidney yang strengthening Chinese traditional medicinal formula and its preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1250247C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102614375A (en) * | 2012-04-12 | 2012-08-01 | 江苏建康职业学院 | Traditional Chinese medicine compound for tonifying kidney, strengthening yang and treating impotence and preparing method thereof |
| CN107137686A (en) * | 2017-05-26 | 2017-09-08 | 合肥丰瑞隆生物科技有限公司 | Help Chinese medicine composition, medicinal liquor of positive beauty and preparation method thereof |
| CN110101813A (en) * | 2019-05-13 | 2019-08-09 | 三亚海王海洋生物科技有限公司 | It is a kind of to treat kidney-yang deficiency oyster composition oral liquid and preparation method thereof and its application |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113171431A (en) * | 2021-06-03 | 2021-07-27 | 绵阳德康疼痛医院 | Capsule for treating rheumatoid and preparation method thereof |
-
2003
- 2003-12-05 CN CNB2003101182259A patent/CN1250247C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102614375A (en) * | 2012-04-12 | 2012-08-01 | 江苏建康职业学院 | Traditional Chinese medicine compound for tonifying kidney, strengthening yang and treating impotence and preparing method thereof |
| CN102614375B (en) * | 2012-04-12 | 2013-09-11 | 江苏建康职业学院 | Traditional Chinese medicine compound for tonifying kidney, strengthening yang and treating impotence and preparing method thereof |
| CN107137686A (en) * | 2017-05-26 | 2017-09-08 | 合肥丰瑞隆生物科技有限公司 | Help Chinese medicine composition, medicinal liquor of positive beauty and preparation method thereof |
| CN110101813A (en) * | 2019-05-13 | 2019-08-09 | 三亚海王海洋生物科技有限公司 | It is a kind of to treat kidney-yang deficiency oyster composition oral liquid and preparation method thereof and its application |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1250247C (en) | 2006-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1208056C (en) | Medicine containing Anemonin as effective component for treating aseptic inflammation | |
| CN1836720A (en) | Chinese medicine composition for treating arthritis or gout and preparing method thereof | |
| CN109674958A (en) | A kind of Chinese medicine composition and its preparation method and application with anti-trioxypurine | |
| CN100528214C (en) | Capsule for treating epilepsia and its preparing method | |
| CN1272055C (en) | Chinese materia medica preparation of prolonging life for invigorating the kidney yang and producing method | |
| CN1250247C (en) | Luyang kidney yang strengthening Chinese traditional medicinal formula and its preparation | |
| CN114470042B (en) | Composition for preventing and treating liver injury of animals as well as preparation method and application thereof | |
| CN1907335A (en) | Pharmaceutical composition for treating nasosinusitis and its preparing process | |
| CN1186067C (en) | Medicine for curing acute injury of muscle and tendon and its preparation method | |
| CN1506090A (en) | Rheum emodi wall extract and medicine composition with the extract as active component | |
| CN100363043C (en) | Chinese traditional medicine composition for treating rheumatic or rheumatoid disease and preparation method thereof | |
| CN101032540A (en) | Medicine composition for curing arthritis and the preparing method and purpose thereof | |
| CN1488394A (en) | Chinese medicine cap sule for treating prostatic disorders | |
| CN1248709C (en) | Chinese medicine prepn for stopping drug addiction | |
| CN1931279A (en) | Medicine for treating biliary tract infection and its prepn process | |
| CN1186052C (en) | Medicine for treatment of pelvic inflammation, its preparation and preparing method | |
| CN1583043A (en) | Duyiwei extract and its preparation and use | |
| CN101053598A (en) | Medicinal composition for treating cardio-cerebralvascular diseases and diabetes | |
| CN1299755C (en) | Cinnamon compound medicine, and its preparing method and use | |
| CN1141113C (en) | Chinese patent medicine for curing peptic ulcer | |
| CN1257735A (en) | Medicine for treating constipation and its preparing process | |
| CN104825784B (en) | A kind of Chinese medicine composition with anti-gastric cancer activity and its preparation method and application | |
| CN1204916C (en) | Medicine for treating depression and its preparation method | |
| CN1258373C (en) | Medicine for treating lumbosacral pain and its preparing method | |
| CN115252742A (en) | Chinese medicinal oral preparation for treating traumatic injury and fracture |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20070618 Pledge (preservation): Preservation |
|
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20080618 Pledge (preservation): Preservation registration |
|
| ASS | Succession or assignment of patent right |
Owner name: LIAOYUAN YULONGYA PHARMACEUTICAL CO.LTD. Free format text: FORMER OWNER: LIAOYUAN YADONG MEDICINE CO., LTD., JILIN PROVINCE Effective date: 20080926 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20080926 Address after: Jilin city of Liaoyuan province Yiyang Friendship Road No. 5 Patentee after: LIAOYUAN YULONGYADONG PHARMACEUTICAL Co.,Ltd. Address before: No. 33 Youyi Road, Jilin, Liaoyuan Patentee before: Jilin Liaoyuan Yadong Pharmaceutical Co.,Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060412 |